Robeco Institutional Asset Management B.V. Sells 344,257 Shares of CME Group Inc. $CME

Robeco Institutional Asset Management B.V. reduced its holdings in shares of CME Group Inc. (NASDAQ:CME) by 53.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 295,339 shares of the financial services provider’s stock after selling 344,257 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.08% of CME Group worth $80,651,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Elevate Capital Advisors LLC boosted its stake in CME Group by 13.9% in the 4th quarter. Elevate Capital Advisors LLC now owns 9,700 shares of the financial services provider’s stock valued at $2,649,000 after purchasing an additional 1,181 shares during the period. Gibbs Wealth Management boosted its stake in CME Group by 14.9% in the 4th quarter. Gibbs Wealth Management now owns 1,643 shares of the financial services provider’s stock valued at $431,000 after purchasing an additional 213 shares during the period. Ritholtz Wealth Management boosted its stake in CME Group by 13.8% in the 4th quarter. Ritholtz Wealth Management now owns 6,759 shares of the financial services provider’s stock valued at $1,846,000 after purchasing an additional 819 shares during the period. Diversify Advisory Services LLC boosted its stake in CME Group by 8.8% in the 4th quarter. Diversify Advisory Services LLC now owns 9,333 shares of the financial services provider’s stock valued at $2,608,000 after purchasing an additional 758 shares during the period. Finally, Carnegie Investment Counsel boosted its stake in CME Group by 0.9% in the 4th quarter. Carnegie Investment Counsel now owns 157,196 shares of the financial services provider’s stock valued at $42,927,000 after purchasing an additional 1,472 shares during the period. 87.75% of the stock is currently owned by institutional investors.

CME Group Price Performance

Shares of NASDAQ CME opened at $295.30 on Monday. The stock has a market capitalization of $105.90 billion, a PE ratio of 26.46, a P/E/G ratio of 3.08 and a beta of 0.26. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.03. The business has a fifty day moving average price of $306.36 and a two-hundred day moving average price of $284.70. CME Group Inc. has a fifty-two week low of $251.90 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating the consensus estimate of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the firm earned $2.52 EPS. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. As a group, equities analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th were issued a dividend of $1.30 per share. This is an increase from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date of this dividend was Tuesday, March 10th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s payout ratio is presently 46.59%.

Insiders Place Their Bets

In other news, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total transaction of $1,097,120.67. Following the completion of the transaction, the general counsel owned 7,192 shares of the company’s stock, valued at approximately $2,397,597.04. The trade was a 31.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Bryan T. Durkin sold 4,200 shares of the business’s stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total value of $1,300,530.00. Following the transaction, the director directly owned 43,007 shares of the company’s stock, valued at $13,317,117.55. This trade represents a 8.90% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 8,539 shares of company stock worth $2,713,821 over the last 90 days. Corporate insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. TD Cowen boosted their price target on CME Group from $328.00 to $340.00 and gave the company a “buy” rating in a research note on Thursday. Weiss Ratings upgraded CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday, March 2nd. UBS Group reaffirmed a “neutral” rating and issued a $310.00 price objective on shares of CME Group in a report on Friday, February 6th. JPMorgan Chase & Co. lifted their price objective on CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a report on Thursday, February 5th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $309.18.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Morgan Stanley raised its price target to $362 and reiterated an “overweight” view, signaling materially higher analyst conviction on CME’s revenue mix and cash returns. Morgan Stanley raise
• Positive Sentiment: TD Cowen raised its target to $340 and kept a “buy” rating — another upside-biased revision supporting upside expectations. TD Cowen upgrade
• Positive Sentiment: CME confirmed it will launch SUI futures in early May, expanding its crypto derivatives product set and opening a new institutional revenue stream. Product expansion is a tangible growth catalyst. SUI futures launch
• Neutral Sentiment: Jefferies trimmed its price target to $349 from $356 but maintained a “buy” rating — a modest downgrade that still implies upside, so impact is mixed. Jefferies PT cut
• Neutral Sentiment: Keefe, Bruyette & Woods began coverage of CME — fresh analyst attention can help liquidity and visibility but the near-term directional effect depends on published views. KBW begins coverage
• Neutral Sentiment: Short-interest data is mixed: reported short interest fell 15.6% in late March to ~4.7M shares (about 1.3% of float, ~2.3 days to cover), which reduces immediate bearish pressure; however, an April 10 reporting entry shows an anomalous “0 shares/NaN” figure, creating data uncertainty for traders. (Internal short-interest reports)
• Negative Sentiment: The White House issued an ethics warning after large, time-sensitive trading in oil futures and gains in prediction markets tied to geopolitical events. That has raised political and regulatory scrutiny of trading venues and prediction/derivatives markets — an elevated oversight risk that could lead to tighter rules or reputational scrutiny for exchanges like CME. White House ethics warning

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.